subscribeSubscribe
CytomX to Present Data for Conditionally Activated Interferon Alpha-2b

CytomX to Present Data for Conditionally Activated Interferon Alpha-2b
GLOBENEWSWIRE
30 Oct 2023
Share Share
BetterLife Initiates Preclinical Study of AP-003 in Delta Variant of SARS-CoV-2

BetterLife Initiates Preclinical Study of AP-003 in Delta Variant of SARS-CoV-2
GLOBENEWSWIRE
25 Aug 2021
Share Share
AOP Orphan Pharmaceuticals presents latest analysis on BESREMi at EHA 2021

AOP Orphan Pharmaceuticals presents latest analysis on BESREMi at EHA 2021
PRESS RELEASE
01 Jul 2021
Share Share
Schering`s Peginterferon Alfa-2B Receives Approval in US

Schering`s Peginterferon Alfa-2B Receives Approval in US
FDA
08 Jan 2019
Share Share
Schering`s Peginterferon Alfa-2B Receives Supplemental Approval in US

Schering`s Peginterferon Alfa-2B Receives Supplemental Approval in US
21 Dec 2018
Share Share
Schering`s Peginterferon Alfa-2B Receives Supplemental Approval in US

Schering`s Peginterferon Alfa-2B Receives Supplemental Approval in US
FDA
21 Dec 2018
Share Share
Seven medicines leap closer to EU approval

Seven medicines leap closer to EU approval
Selina McK PHARMA TIMES
18 Dec 2018
Share Share
PharmaEssentia, AOP Orphan Receive +ve CHMP Opinion For Ropeginterferon alfa-2b

PharmaEssentia, AOP Orphan Receive +ve CHMP Opinion For Ropeginterferon alfa-2b
PR NEWSWIRE
17 Dec 2018
Share Share
Meeting highlights from the CHMP 10-13 December 2018

Meeting highlights from the CHMP 10-13 December 2018
14 Dec 2018
Share Share
Schering’s Intron (Interferon Alfa-2b) Receives Supplemental Approval In US

Schering’s Intron (Interferon Alfa-2b) Receives Supplemental Approval In US
FDA
13 Jun 2017
Share Share